[1] Evans R M,Barish G D, Wang Y X. PPARs and the complex journey to obesity. Nature Medicine,2004,10(4):355-361.
[2] Schaffer J E. Lipotoxicity: when tissues overeat. Current Opinion in Lipidology,2003,14(3):281-287.
[3] Adams L A,Angulo PLindor K D. Nonalcoholic fatty liver disease. Canadian Medical Association Journal,2005,172(7):899-905.
[4] Adams L A,Lymp J F,St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology,2005,129(1):113-121.
[5] Crabb D W,Galli A,Fischer M, et al. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol,2004,34(1):35-38.
[6] Cohen J C,Horton J D,Hobbs H H. Human fatty liver disease: old questions and new insights. Science,2011,332(6037):1519-1523.
[7] Sunny N E,Parks E J,Browning J D, et al. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metabolism,2011,14(6):804-810.
[8] Guo Y,Darshi M,Ma Y, et al. Quantitative proteomic and functional analysis of liver mitochondria from high fat diet (HFD) diabetic mice. Molecular & Cellular Proteomics,2013,12(12):3744-3758.
[9] Blake W L,Clarke S D. Suppression of rat hepatic fatty acid synthase and S14 gene transcription by dietary polyunsaturated fat. The Journal of Nutrition,1990,120(12):1727-1729.
[10] Jump D B,Clarke S D. Regulation of gene expression by dietary fat. Annu Rev Nutr,1999,19(1):63-90.
[11] Jump D B,Clarke S D,MacDougald O, et al. Polyunsaturated fatty acids inhibit S14 gene transcription in rat liver and cultured hepatocytes. Proceedings of the National Academy of Sciences of the United States of America,1993,90(18):8454-8458.
[12] Vaquerizas J M,Kummerfeld S K,Teichmann S A, et al. A census of human transcription factors: function, expression and evolution. Nature Reviews Genetics,2009,10(4):252-263.
[13] Ding C,Chan D W,Liu W, et al. Proteome-wide profiling of activated transcription factors with a concatenated tandem array of transcription factor response elements. Proceedings of the National Academy of Sciences of the United States of America,2013,110(17):6771-6776.
[14] Jump D B. Fatty acid regulation of hepatic lipid metabolism. Current Opinion in Clinical Nutrition and Metabolic Care,2011,14(2):115-120.
[15] Ren B,Thelen A P,Peters J M, et al. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. The Journal of Biological Chemistry,1997,272(43):26827-26832.
[16] Wang Y,Botolin D,Xu J, et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. Journal of Lipid Research,2006,47(9):2028-2041.
[17] Postic C,Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. The Journal of Clinical Investigation,2008,118(3):829-838.
[18] Lee J Y,Plakidas A,Lee W H, et al. Differential modulation of toll-like receptors by fatty acids preferential inhibition by n-3 polyunsaturated fatty acids. Journal of Lipid Research,2003,44(3):479-486.
[19] Ribeiro P S,Cortez-Pinto H,Sola S, et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. The American Journal of Gastroenterology,2004,99(9):1708-1717.
[20] Jump D B,Tripathy S,Depner C M. Fatty acid regulated transcription factors in the liver. Annual Review of Nutrition,2013,33(4):249-249.
[21] Gu L Y,Qiu L W,Chen X F, et al. Oleic acid induced hepatic steatosis is coupled with downregulation of aquaporin 3 and upregulation of aquaporin 9 via activation of p38 signaling. Hormone and Metabolic Research,2014,13(3):125-129.
[22] Hwang Y J,Wi H R,Kim H R, et al. Pinus densiflora Sieb. et Zucc. alleviates lipogenesis and oxidative stress during oleic acid-induced steatosis in HepG2 cells. Nutrients,2014,6(7):2956-2972.
[23] Holzer R G,Park E J,Li N, et al. Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell,2011,147(1):173-184.
[24] Listenberger L L,Han X,Lewis S E, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proceedings of the National Academy of Sciences,2003,100(6):3077-3082.
[25] Wu H T,Chen W,Cheng K C, et al. Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells. The Journal of Nutritional Biochemistry,2012,23(10):1264-1270.
[26] Chen Y,Billadello J J,Schneider D J. Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene. Arteriosclerosis, Thrombosis, and Vascular Biology,2000,20(12):2696-2701.
[27] Byon C H,Hardy R W,Ren C, et al. Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4. Laboratory Investigation; A Journal of Technical Methods and Pathology,2009,89(11):1221-1228.
[28] Reyes-Quiroz M E,Alba G,Saenz J, et al. Oleic acid modulates mRNA expression of liver X receptor (LXR) and its target genes ABCA1 and SREBP1c in human neutrophils. European Journal of Nutrition,2014,7(3):1-11.
[29] Zor T,Selinger Z. Linearization of the bradford protein assay increases its sensitivity: theoretical and experimental studies. Analytical Biochemistry,1996,236(2):302-308.
[30] Schwanhausser B,Busse D,Li N, et al. Global quantification of mammalian gene expression control. Nature,2011,473(7347):337-342.
[31] Arkan M C,Hevener A L,Greten F R, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nature Medicine,2005,11(2):191-198.
[32] Cai D,Yuan M,Frantz D F, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature Medicine,2005,11(2):183-190.
[33] Dietze R,Konrad L,Shihan M, et al. Cardiac glycoside ouabain induces activation of ATF-1 and StAR expression by interacting with the alpha4 isoform of the sodium pump in Sertoli cells. Biochimica et Biophysica Acta,2013,1833 (3):511-519.
[34] Gan B,Lim C,Chu G, et al. FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis. Cancer cell,2010,18(5):472-484.
[35] Lu M,Lawrence D A,Marsters S, et al. Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. Science,2014,345(6192):98-101.
[36] Kaufman R J, Cao S. Inositol‐requiring 1/X‐box‐binding protein 1 is a regulatory hub that links endoplasmic reticulum homeostasis with innate immunity and metabolism. EMBO Molecular Medicine,2010,2(6):189-192.
[37] Verfaillie T,Salazar M,Velasco G, et al. Linking ER stress to autophagy: potential implications for cancer therapy. International Journal of Cell Biology,2010,7(4):352-356.
[38] Klune J R,Dhupar R,Cardinal J, et al. HMGB1: endogenous danger signaling. Molecular Medicine,2008,14(7):476-476.
[39] Ohmori H,Luo Y,Kuniyasu H. Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer. Expert Opinion on Therapeutic Targets,2011,15(2):183-193.
[40] Andres-Hernando A,Lanaspa M A,Rivard C J, et al. Nucleoporin 88 (Nup88) is regulated by hypertonic stress in kidney cells to retain the transcription factor tonicity enhancer-binding protein (TonEBP) in the nucleus. Journal of Biological Chemistry,2008,283(36):25082-25090.
[41] Hofmanova J,Vaculova A,Kozubik A. Polyunsaturated fatty acids sensitize human colon adenocarcinoma HT-29 cells to death receptor-mediated apoptosis. Cancer Letters,2005,218(1):33-41.
[42] Schley P D,Brindley D N,Field C J. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. The Journal of Nutrition,2007,137(3):548-553.
[43] Kadonaga J T. Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors. Cell,2004,116(2):247-257.
|